SU5416
STEMCELL Technologies Inc.Tyrosine kinase inhibitor; Inhibits of KDR, PDGFR, KIT, RET, FLT-3, ABL and ALK
Tyrosine kinase inhibitor; Inhibits of KDR, PDGFR, KIT, RET, FLT-3, ABL and ALK
Cyclin/CDK pathway inhibitor; Inhibits CDK1 and CDK2
Tryosine kinase inhibitor and epigenetic modifier; Inhibits PDGF, FGF, EGF, TGFß, SIRT1, and SIRT5
Estrogen signaling pathway modulator; Modulates selective estrogen receptor and estrogen-related receptor
mTOR pathway inhibitor; Inhibits mTORC1 and mTORC2 complexes
Epigenetic modifier; Inhibits lysine-specific demethylase 1 (LSD1)
Epigenetic modifier; Inhibits histone deacetylase (HDAC)1 and HDAC6
Retinoid pathway activator; Activates retinoic acid receptor (RAR)
MEK/ERK pathway inhibitor; Inhibits MEK1 and MEK2
Pyrimido-indole derivative that enhances HSC self-renewal in vitro
Epigenetic modifier; Inhibits histone deacetylase (HDAC)1
Regulated upon activation, normal T cell expressed and secreted
Xeno-free, defined, feeder-free medium for maintenance of undifferentiated human ES and iPS cells
Defined, animal component-free medium for differentiation of human ES and iPS cells to multiple lineages
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells
Enzyme-free cell dissociation reagent
Animal component-free suspension culture medium for human ES and iPS cells
Immunomagnetic negative selection from whole blood kit
Immunomagnetic negative selection kit from whole blood
Immunomagnetic negative selection from whole blood kit